Global Psychedelic Survey
Launching May 1, 2025
We are thrilled to announce the upcoming launch of the Global Psychedelic Survey 2025. Join us as we undertake the most comprehensive assessment of global psychedelic use amongst adults to date.
This year’s survey will be available in several languages as we seek to hear diverse experiences from participants around the globe.

Who is eligible to participate?
- Adults ages 21 and older
- Must have consumed a psychedelic substance. Substances may include but are not limited to psilocybin-containing mushrooms, LSD (lysergic acid diethylamide), MDMA (3,4-Methylenedioxymethamphetamine), ketamine, ayahuasca, and nitrous oxide.
What can participants expect?
- Survey completion should take participants 30-40 minutes
- Participation is anonymous and voluntary
GPS in the News
- OPEN Foundation: The Global Psychedelic Survey 2025 — A Study of International Naturalistic Psychedelic Use
- The Fundamentals Podcast: Researching Psychedelics — An Interview with Dr. George Mashour
Study Team

Jacob Aday, PhD
PI - University of Michigan

Stephanie Lake, PhD
PI - UCLA

Philippe Lucas, PhD
PI - University of Michigan

Daniel Kruger, PhD
PI - University of Buffalo

Kevin Boehnke, PhD
University of Michigan

George Mashour, MD, PhD
University of Michigan
Collaborators
- Eric Baron
- Galia Benitez Cabrera
- Jaz Cadoch
- Adam Crosland
- Jules Evans
- Alli Feduccia
- Albert Garcia-Romeu
- Jamarie Geller
- Sean Goldy
- Marianna Graziosi
- Matthew Johnson
- Tony Larkin
- Christine McLeave
- Christopher Nicholas
- Danielle Nova
- Rachel Pacilio
- Niloufar Pouyan
- Marlena Robbins
- David Yaden
- Sue-Ling Chang
- Michel Dorval
- Sara Gloeckler
- Kyle Greenway
- Noor Hussain Ramadhan
- Alexandre Lehmann
- Julien Levesque
- Rotem Petranker
- Jill Robinson
- Omer Syed
- Baeleigh VanderZwaag
- Zach Walsh
- Agnieszka Bojanowska
- Joost Breeksema
- Matteo Buonarroti
- Chiara Caporusciochi
- Ksenia Cassidy
- Mauro D’Alonzo
- Bengican Guelegen
- David Luke
- Yustyna Miskiv
- Celia Morgan
- Oleh Orlov
- Giuseppe Pasculli
- Dimitris Repantis
- Oliver Robinson
- Gijs Roelandt
- Eugenio Rossi
- Mika Tsupari
- Joao Ariel
- Lucia Levenberg
- Tulio Pereira
- Julio Silva
- Guilherme Soriano Adan
- Mahmoud Elmiday
- Saad Maida
- Mourab Wahba
- Manzar Zare
- Futaba Umemura
- Karen Yan
- Christina Ni
- Paul Liknaitzky
- Diego Pinzon
- Alvita Sam
- Suresh Sundram
- Sam Lasham
- Ryan Ward
- Jai Whelan
- Pinni Baumol
- Lior Kritzman
Survey Distribution Partners
Our thanks to the distribution partners who are helping to ensure that voices from across the world can participate in the Global Psychedelic Survey 2025.
2023 Survey Results
Your voice can have an impact. Our colleagues at SABI Mind, Multidisciplinary Association of Psychedelic Studies (MAPS), Mind Medicine Australia, and Tiny sponsored the 2023 Global Psychedelic Survey, which included more than 6,000 participants from around the world. Learn more about how the voices of 2023 advanced the science of psychedelics:
- Racial differences in naturalistic psychedelic use — motivations for use, communication with health care providers, and outcomes. Glynos NG, Reid MR, Aday JS, Kruger DJ, Boehnke KF, Lake S, Lucas P. Journal of Psychoactive Drugs. April 2025.
- Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use. Glynos NG, Baker A, Aday JS, Kruger D, Boehnke KF, Lake S, Lucas P. British Journal of Pain. February 2025.
- Preferences, perceptions, and environmental considerations of natural and synthetic psychedelic substances: Findings from the Global Psychedelic Survey. Syed OA, Petranker R, Fewster EC, Sobolenko V, Beads Z, Husain MI, Lake S, Lucas P. Journal of Psychoactive Drugs. 24 December 2024.
- Developing a short form of the Awe Experience Scale (AWE-SF) in psychedelic samples. Graziosi M, Rohde JS, Lake S, Lucas P, Kaufman SB, Yaden DB. PLOS One. 4 December 2024.
- Global trends in psychedelic microdosing: Demographics, substance testing behavior, and patterns of use. Syed OA, Petranker R, Fewster EC, Sobolenko V, Beidas Z, Husain MI, Lake S, Lucas P. Journal of Psychoactive Drugs. 6 November 2024.
- Co-use of psychedelics with other substances: Findings from the global psychedelic survey. Lake S, Lucas P. Journal of Psychopharmacology. 28 October 2024.
- The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world. Lake S, Lucas P. International Journal of Drug Policy. August 2024.
- Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey. Glynos NA, Aday JS, Kruger D, Boehnke KF, Lake S, Lucas P. Frontiers in Psychiatry. 21 February 2024.